BRPI0520797A2 - forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma droga - Google Patents

forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma droga

Info

Publication number
BRPI0520797A2
BRPI0520797A2 BRPI0520797-5A BRPI0520797A BRPI0520797A2 BR PI0520797 A2 BRPI0520797 A2 BR PI0520797A2 BR PI0520797 A BRPI0520797 A BR PI0520797A BR PI0520797 A2 BRPI0520797 A2 BR PI0520797A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical tablet
pharmaceutical
breaking
drug
tablet
Prior art date
Application number
BRPI0520797-5A
Other languages
English (en)
Inventor
Lawrence Solomon
Allan S Kaplan
Original Assignee
Accu Break Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accu Break Technologies Inc filed Critical Accu Break Technologies Inc
Publication of BRPI0520797A2 publication Critical patent/BRPI0520797A2/pt
Publication of BRPI0520797B1 publication Critical patent/BRPI0520797B1/pt
Publication of BRPI0520797B8 publication Critical patent/BRPI0520797B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMA DE DOSAGEM FARMACêUTICA, COMPRIMIDO FARMACêUTICO, MéTODO PARA QUEBRAR UM COMPRIMIDO FARMACêUTICO, MéTODO DE ADMINISTRAçãO DE UMA DOSE PARCIAL DE UMA DROGA CONTIDA EM UM COMPRIMIDO FARMACêUTICO, MéTODO PARA REDUZIR O RISCO OU IMPEDIR A CONFUSãO DO PACIENTE EM UM TRATAMENTO, COMPRIMIDO FARMACêUTICO PRENSADO, MéTODO PARA QUEBRAR UM COMPRIMIDO FARMACêUTICO PRENSADO E MéTODO PARA A CRIAçãO DE UMA QUANTIDADE PRECISA DE UMA DROGA. Trata-se de um comprimido farmacêutico adaptado para a divisão exata de uma dose de uma droga em duas, ou em doses menores, sendo que o comprimido tem dois ou mais segmentos.
BRPI0520797A 2005-11-18 2005-11-18 forma de dosagem farmacêutica comprimida em bicamadas BRPI0520797B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/042120 WO2007058660A1 (en) 2005-11-18 2005-11-18 Segmented pharmaceutical dosage forms

Publications (3)

Publication Number Publication Date
BRPI0520797A2 true BRPI0520797A2 (pt) 2009-06-09
BRPI0520797B1 BRPI0520797B1 (pt) 2020-06-09
BRPI0520797B8 BRPI0520797B8 (pt) 2021-05-25

Family

ID=38048942

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0520797A BRPI0520797B8 (pt) 2005-11-18 2005-11-18 forma de dosagem farmacêutica comprimida em bicamadas

Country Status (9)

Country Link
US (2) US8231902B2 (pt)
EP (1) EP1948138A4 (pt)
JP (1) JP5259413B2 (pt)
CN (1) CN101351195A (pt)
AU (1) AU2005338350A1 (pt)
BR (1) BRPI0520797B8 (pt)
CA (1) CA2630154C (pt)
MX (1) MX2008006453A (pt)
WO (1) WO2007058660A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080075772A1 (en) * 2006-04-13 2008-03-27 Lawrence Solomon Pharmaceutical compositions having novel scoring patterns and methods of using those compositions
CA2657437A1 (en) * 2006-06-19 2007-12-27 Accu-Break Technologies, Inc. Segmented pharmaceutical dosage forms
US20110280936A1 (en) * 2010-05-17 2011-11-17 Aptapharma, Inc. Self Breaking Tablets
WO2011160178A1 (en) * 2010-06-24 2011-12-29 Carina Hiley Insect bait
WO2013030725A1 (en) * 2011-08-26 2013-03-07 Wockhardt Limited Methods for treating cardiovascular disorders
JP2015034133A (ja) * 2013-08-07 2015-02-19 直実 植木 分割錠剤
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
BR112020017422A2 (pt) 2018-03-29 2020-12-22 Avion Pharmaceuticals , Llc Composição de dose fracionada de levodopa e uso
CN111407734A (zh) * 2019-01-05 2020-07-14 厦门赛诺邦格生物科技股份有限公司 一种阳痿早泄治疗药物的固体制剂
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128226A (en) 1962-08-22 1964-04-07 Hoffmann La Roche Composition for relieving pain
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
US3517871A (en) * 1968-11-15 1970-06-30 James P Gaffney Tablet cutter
US3927194A (en) * 1972-12-06 1975-12-16 Ives Lab Inc Tablet formulation
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
US4215104A (en) * 1979-03-26 1980-07-29 Mead Johnson & Company Multi-fractionable tablet structure
CH648754A5 (en) * 1979-08-16 1985-04-15 Ciba Geigy Ag Pharmaceutical slow release tablet
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4789546A (en) * 1987-02-19 1988-12-06 Consumer Products Corp. Multiple-layer tablet with contrasting organoleptic characteristics
US5158728A (en) 1991-04-12 1992-10-27 Elizabeth-Hata International, Inc. Multi-layer medicinal tablet forming machine and method for using the same
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
CA2110313C (en) 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
JP3168582B2 (ja) * 1993-12-10 2001-05-21 藤沢薬品工業株式会社 解熱鎮痛配合剤
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
TW483763B (en) 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
IT1282576B1 (it) 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
DE19927688A1 (de) 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
EP1355633B1 (en) * 2001-12-19 2005-01-19 AstraZeneca AB NEW FILM COATING containing an ethyl acrylate/methyl methacrylate copolymer and polyvinyl acetate
NZ534039A (en) 2002-01-15 2006-08-31 Ucb Farchim S Formulations of pharmaceutical compositions for oral administration
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
EP1499295A4 (en) * 2002-04-05 2006-04-05 Penwest Pharmaceuticals Co EXTENDED RELEASE METOPROLOL FORMULATIONS
BRPI0410555A (pt) 2003-06-06 2006-06-20 Takeda Pharmaceutical preparação sólida
EP1648422A4 (en) * 2003-07-28 2007-09-19 Reddys Lab Inc Dr TREATMENT AND PREVENTION OF CARDIOVASCULAR ACCIDENTS
ES2336142T3 (es) * 2005-08-19 2010-04-08 Aventis Pharmaceuticals Inc. Combinacion de un agente hipnotico y un compuesto sustituido, con bis arilo y heteroarilo y aplicacion terapeutica del mismo.

Also Published As

Publication number Publication date
JP5259413B2 (ja) 2013-08-07
EP1948138A1 (en) 2008-07-30
CN101351195A (zh) 2009-01-21
JP2009515955A (ja) 2009-04-16
WO2007058660A1 (en) 2007-05-24
MX2008006453A (es) 2009-01-28
BRPI0520797B1 (pt) 2020-06-09
US20110300208A1 (en) 2011-12-08
EP1948138A4 (en) 2012-07-11
CA2630154A1 (en) 2007-05-24
US20080233190A1 (en) 2008-09-25
AU2005338350A1 (en) 2007-05-24
BRPI0520797B8 (pt) 2021-05-25
US8231902B2 (en) 2012-07-31
CA2630154C (en) 2015-06-16

Similar Documents

Publication Publication Date Title
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
PH12016500619A1 (en) Dry powder inhaler
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
BR112012000862A8 (pt) composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento
NZ600257A (en) Device and method for delivery of two or more drug agents
AR050418A1 (es) Dosificacion fija de anticuerpos her
BRPI0418029B8 (pt) formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
MX2010009447A (es) Uso de antagonistas de lhrh a dosis no castrantes.
GT200500003A (es) Composicion farmaceutica apta para la compresion directa para la administracion oral de cci-779
BR112015022465A2 (pt) método para tratamento não-tóxico para síndrome de abstinência de drogas
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
WO2012052853A3 (en) Oral dosing device for administration of medication
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BRPI0520797A2 (pt) forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma droga
BR112018068784A2 (pt) método para o tratamento de leucemia
AR104771A1 (es) Inhalador de polvo seco
NZ769954A (en) Syringe devices for use in an emergency
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
AR065139A1 (es) Medicamento para el tratamiento de la endometriosis
MX2015009546A (es) Dosificacion aumentada de efavirenz para el tratamiento de cancer.
Sturn et al. Low-dose naltrexone: a new therapy option for complex regional pain syndrome type I patients
MX2015016418A (es) Dihidroetorfina para proporcionar el alivio del dolor y la anestesia.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2162 DE 12/06/2012.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24D Patent annual fee: restoration after fee payment